Literature DB >> 8913314

Severe congenital neutropenia terminating in acute myeloid leukemia: disease progression associated with mutations in the granulocyte-colony stimulating factor receptor gene.

I P Touw1, F Dong.   

Abstract

Severe congenital neutropenia (SCN) is a heterogeneous disease condition with a variable family history and a propensity to progress towards myelodysplastic syndrome (MDS) and acute myeloblastic leukemia (AML). In a subgroup of patients, point mutations in the G-CSF-R gene have been found. These nonsense mutations result in the truncation of the C-terminal cytoplasmic region, a subdomain that is crucial for G-CSF induced maturation. SCN patients with mutations in the G-CSF-R gene appear to be predisposed to develop AML. Here, we recapitulate our view of how defective G-CSF-R may contribute to neutropenia and leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913314     DOI: 10.1016/0145-2126(96)00017-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

Review 1.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

3.  Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.

Authors:  Shashidhar S Jatiani; Stacey J Baker; Lewis R Silverman; E Premkumar Reddy
Journal:  Genes Cancer       Date:  2010-10

4.  Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor.

Authors:  Elaine M Sloand; Agnes S M Yong; Shakti Ramkissoon; Elena Solomou; Tullia C Bruno; Sonnie Kim; Monika Fuhrer; Sachiko Kajigaya; A John Barrett; Neal S Young
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-15       Impact factor: 11.205

5.  A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments GCSF proliferation activity but not through the MAP kinase cascade.

Authors:  Toshihiro Yokoyama; Seiichi Okamura; Yoshinobu Asano; Kenjirou Kamezaki; Akihiko Numata; Haruko Kakumitsu; Koutarou Shide; Hitoshi Nakashima; Kanaji Taisuke; Yuichi Sekine; Yumi Mizuno; Jun Okamura; Tadashi Matsuda; Mine Harada; Niho Yoshiyuki; Kazuya Shimoda
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

6.  A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition.

Authors:  Shashidhar S Jatiani; Stephen C Cosenza; M V Ramana Reddy; Ji Hee Ha; Stacey J Baker; Ajoy K Samanta; Matthew J Olnes; Loretta Pfannes; Elaine M Sloand; Ralph B Arlinghaus; E Premkumar Reddy
Journal:  Genes Cancer       Date:  2010-04

7.  Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.

Authors:  Amy M Trottier; Lawrence J Druhan; Ira L Kraft; Amanda Lance; Simone Feurstein; Maria Helgeson; Jeremy P Segal; Soma Das; Belinda R Avalos; Lucy A Godley
Journal:  Blood Adv       Date:  2020-10-27

8.  Divergent pathways in COS-7 cells mediate defective internalization and intracellular routing of truncated G-CSFR forms in SCN/AML.

Authors:  Melissa G Hunter; Morgan McLemore; Daniel C Link; Megan Loveland; Alexander Copelan; Belinda R Avalos
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

9.  G-CSFR ubiquitination critically regulates myeloid cell survival and proliferation.

Authors:  Jing Ai; Lawrence J Druhan; Megan J Loveland; Belinda R Avalos
Journal:  PLoS One       Date:  2008-10-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.